DEFINITIVE SCHEDULE 14A

Company

TENAX THERAPEUTICS, INC.

Filed

November 4, 2013

Period of Report

December 4, 2013

Accession Number

0001354488-13-005972

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →